Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.400
-0.070 (-2.02%)
May 13, 2025, 4:00 PM - Market closed
Clover Health Investments Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Investments in Debt Securities | 230.75 | 216.06 | 121 | 138.11 | 175.94 | 54.39 | Upgrade
|
| Other Investments | 4.66 | 27.01 | 119.82 | 230.97 | 315.29 | 4.36 | Upgrade
|
| Total Investments | 235.41 | 243.07 | 240.82 | 369.08 | 491.23 | 58.76 | Upgrade
|
| Cash & Equivalents | 155.44 | 194.54 | 116.41 | 103.79 | 299.97 | 92.35 | Upgrade
|
| Other Receivables | 138.26 | 92.79 | 86.24 | 167.55 | 109.42 | 84.94 | Upgrade
|
| Property, Plant & Equipment | 5.03 | 5.31 | 5.08 | 9.78 | 7.65 | 9.96 | Upgrade
|
| Goodwill | - | - | - | 11.75 | 1.24 | 1.23 | Upgrade
|
| Other Intangible Assets | 2.99 | 2.99 | 2.99 | 8.25 | 2.99 | 3 | Upgrade
|
| Other Current Assets | 33.06 | 28.78 | 105.5 | 122.69 | 27.87 | 8.13 | Upgrade
|
| Other Long-Term Assets | 13.54 | 13.26 | 13.63 | 15.74 | 10.43 | 8.89 | Upgrade
|
| Total Assets | 583.72 | 580.74 | 570.67 | 808.62 | 950.8 | 267.25 | Upgrade
|
| Accounts Payable | 30.55 | 34.56 | 37.18 | 32.45 | 28.13 | 30.67 | Upgrade
|
| Accrued Expenses | 30.52 | 19.09 | 20.95 | 25.53 | 17.47 | 3.98 | Upgrade
|
| Insurance & Annuity Liabilities | - | - | - | 7.24 | 110.63 | - | Upgrade
|
| Unpaid Claims | 151.04 | 156.4 | 137.1 | 141.95 | 138.6 | 102.43 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 20.8 | Upgrade
|
| Current Portion of Leases | - | - | - | 1.83 | 3.06 | 4.8 | Upgrade
|
| Long-Term Debt | - | - | - | - | 19.94 | 106.41 | Upgrade
|
| Long-Term Leases | - | - | - | 4.03 | 4.83 | 6.35 | Upgrade
|
| Other Current Liabilities | 3.54 | 3.47 | 65.88 | 222.52 | 74.74 | 1.55 | Upgrade
|
| Other Long-Term Liabilities | 31.99 | 26.08 | 23.16 | 16.19 | 14.1 | 155.71 | Upgrade
|
| Total Liabilities | 247.64 | 239.6 | 284.28 | 451.73 | 411.49 | 432.7 | Upgrade
|
| Preferred Stock, Convertible | - | - | - | - | - | 447.75 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 2,603 | 2,576 | 2,461 | 2,319 | 2,154 | 411.87 | Upgrade
|
| Retained Earnings | -2,204 | -2,203 | -2,160 | -1,946 | -1,617 | -1,029 | Upgrade
|
| Treasury Stock | -62.95 | -30.99 | -12.73 | -6.51 | -0.15 | - | Upgrade
|
| Comprehensive Income & Other | -0.07 | -1.58 | -2.37 | -9.37 | -1.93 | 0.01 | Upgrade
|
| Total Common Equity | 336.08 | 341.14 | 286.39 | 356.89 | 535.41 | -617.1 | Upgrade
|
| Minority Interest | - | - | - | - | 3.9 | 3.9 | Upgrade
|
| Shareholders' Equity | 336.08 | 341.14 | 286.39 | 356.89 | 539.32 | -165.45 | Upgrade
|
| Total Liabilities & Equity | 583.72 | 580.74 | 570.67 | 808.62 | 950.8 | 267.25 | Upgrade
|
| Filing Date Shares Outstanding | 506.54 | 510.91 | 495.29 | 479.55 | 473.26 | 472.8 | Upgrade
|
| Total Common Shares Outstanding | 506.54 | 503.53 | 489.05 | 478.39 | 470.84 | 89.21 | Upgrade
|
| Total Debt | - | - | - | 5.86 | 27.83 | 138.36 | Upgrade
|
| Net Cash (Debt) | 155.44 | 194.54 | 116.41 | 97.93 | 272.14 | -46.01 | Upgrade
|
| Net Cash Growth | -23.77% | 67.12% | 18.87% | -64.02% | - | - | Upgrade
|
| Net Cash Per Share | 0.32 | 0.40 | 0.24 | 0.21 | 0.66 | -0.52 | Upgrade
|
| Book Value Per Share | 0.66 | 0.68 | 0.59 | 0.75 | 1.14 | -6.92 | Upgrade
|
| Tangible Book Value | 333.09 | 338.15 | 283.4 | 336.89 | 531.18 | -621.33 | Upgrade
|
| Tangible Book Value Per Share | 0.66 | 0.67 | 0.58 | 0.70 | 1.13 | -6.97 | Upgrade
|
| Machinery | - | 0.15 | 0.15 | 0.32 | 0.15 | 0.13 | Upgrade
|
| Leasehold Improvements | - | 3.04 | 3.04 | 3.04 | 3.04 | 3.09 | Upgrade
|
Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.